Regulating Amateurs

How should the government ensure the safety and responsibility of do-it-yourself biologists?

Written byDustin T. Holloway
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© O'LUK/ISTOCKPHOTO.COM

In 2010, scientists at the J. Craig Venter Institute synthesized the entire genome of a cell from basic building blocks, marking an important milestone in the quest to create life from off-the-shelf chemicals. While this technology promises many medical and industrial benefits, it also raises questions about the risks of unregulated biotechnology. After Venter’s announcement, President Barack Obama wrote a letter tasking his Commission for the Study of Bioethical Issues to explore the benefits and dangers posed by synthetic biology. While the commission’s report, released in December 2010, provides key recommendations for the oversight of synthetic biology that have led to actual regulations, it has little to say about the do-it-yourself biology (DIYbio) movement—the practice of self-taught or informally trained individuals running experiments in makeshift ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies